Cinven

Cinven is an international private equity firm with a New York presence as well as European offices, focused on building platforms in pharma, therapeutics, and clinical diagnostics. The firm pursues large, control-oriented buyouts of established healthcare businesses, often spanning multiple geographies. AI is not stated as a dedicated theme; the focus is operating scale and platform building.

Check sizes are $25M and above, with most deals running far larger. Deployment is cross-border, particularly across North America and Europe. Specific portfolio companies in the healthcare AI segment are not provided in the source data.

For healthcare AI founders, Cinven is not a near-term target. The relevant counterpart is a scaled pharma services, diagnostics, or therapeutics company contemplating a control transaction, often at hundreds of millions of revenue or higher. Early and growth-stage AI founders should focus their fundraising elsewhere and treat Cinven as a long-horizon name only.